D. TÜRKDOĞAN Et Al. , "Ketogenic diet as a successful early treatment modality for SCN2A mutation," BRAIN & DEVELOPMENT , vol.41, no.4, pp.389-391, 2019
TÜRKDOĞAN, D. Et Al. 2019. Ketogenic diet as a successful early treatment modality for SCN2A mutation. BRAIN & DEVELOPMENT , vol.41, no.4 , 389-391.
TÜRKDOĞAN, D., Thomas, G., & Demirel, B., (2019). Ketogenic diet as a successful early treatment modality for SCN2A mutation. BRAIN & DEVELOPMENT , vol.41, no.4, 389-391.
TÜRKDOĞAN, DİLŞAD, Gulten Thomas, And Birsen Demirel. "Ketogenic diet as a successful early treatment modality for SCN2A mutation," BRAIN & DEVELOPMENT , vol.41, no.4, 389-391, 2019
TÜRKDOĞAN, DİLŞAD Et Al. "Ketogenic diet as a successful early treatment modality for SCN2A mutation." BRAIN & DEVELOPMENT , vol.41, no.4, pp.389-391, 2019
TÜRKDOĞAN, D. Thomas, G. And Demirel, B. (2019) . "Ketogenic diet as a successful early treatment modality for SCN2A mutation." BRAIN & DEVELOPMENT , vol.41, no.4, pp.389-391.
@article{article, author={DİLŞAD TÜRKDOĞAN Et Al. }, title={Ketogenic diet as a successful early treatment modality for SCN2A mutation}, journal={BRAIN & DEVELOPMENT}, year=2019, pages={389-391} }